Analyst Ratings for Microchip Technology

Analysts have provided the following ratings for Microchip Technology (NASDAQ:MCHP) within the last quarter: Bullish Somewhat Bullish Indifferent…

Analysts have provided the following ratings for Microchip Technology (NASDAQ:MCHP) within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 3 3 0 0
Last 30D 1 0 0 0 0
1M Ago 0 0 0 0 0
2M Ago 0 1 0 0 0
3M Ago 1 2 3 0 0

These 8 analysts have an average price target of $91.25 versus the current price of Microchip Technology at $89.72, implying upside.

Below is a summary of how these 8 analysts rated Microchip Technology over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

price target chart

This current average represents a 3.07% decrease from the previous average price target of $94.14.

Stay up to date on Microchip Technology analyst ratings.

What Are Analyst Ratings?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Microsoft Represents Solid Reacceleration Story in 2024 – Bank of America Analyst Raises Forecast

B of A Securities analyst Brad Sills maintains a Buy rating on Microsoft Corp (NASDAQ: MSFT), uplifting the price target from $430 to $450, anticipating a robust second-quarter revenue growth. The increase reflects a 1% constant currency upside to $60.9 billion, driven by Azure and M365, despite weaker PC shipments. Sills highlights a potential 2% point currency tailwind and foresees significant growth in Azure, driven by new workload migrations and adoption of Microsoft's security solutions.

MSFT

Read More

Investor Caution – Medtronic’s Rocky Road Ahead For Hypertension Device

The FDA Circulatory System Devices Panel vote was closely divided on the benefit/risk profile of Medtronic Plc's (NYSE: MDT) device (tied at 6-6 and one abstention), with the panel chair breaking the tie, resulting in a final 6-7 vote, recommending against the approval of the blood pressure treat

MDT